We Acquire Leading Preclinical Services Provider T3 Labs

We are proud to announce the acquisition of T3 Labs, a renowned preclinical services provider with a strong reputation for advancing medical research and innovation. This acquisition reflects our commitment to strengthening our capabilities in preclinical testing, accelerating the development of medical devices and therapies, and supporting our clients from early research through to clinical success. T3 Labs’ exceptional team, state-of-the-art facilities, and robust scientific expertise will be a valuable addition to our organization as we continue to expand our reach and impact in the healthcare and life sciences industries.